on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3 with the Irish Takeover Panel concerning its stake in Mural Oncology plc. The disclosure, dated September 16, 2025, reveals Vanguard's interest in Mural Oncology, with relevant securities amounting to 771,011 shares, representing 4.46% ownership.
The filing follows the guidelines set by the Irish Takeover Panel Act, 1997, and 2022 Takeover Rules. It requires interested parties holding 1% or more in relevant securities to disclose their positions. Vanguard's filing includes information about ordinary shares related to Mural Oncology valued at $0.01 each.
No cash-settled or stock-settled derivatives positions were disclosed, and there are no indemnity agreements or options arrangements reported by Vanguard in connection with this disclosure. The company has actively participated by selling 240 securities at a price of 2.07 USD each.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news